2 unchanged sentences
The repurchase program has no termination date and may be suspended or discontinued at any time.
−Removed: The following table summarizes the Company’s purchases of common stock under the share repurchase program during the fiscal quarter ended May 31, 2023:
+Added: The following table summarizes the Company’s purchases of common stock under the share repurchase program during the fiscal quarter ended August 31, 2023:
Period Total number of shares
4 unchanged sentences
purchased under the program (in thousands)
−Removed: March 1, 2023 - March 31, 2023 39,923 $ 132.71 39,084 $ 339,143
−Removed: April 1, 2023 - April 30, 2023 845 $ 119.36 — $ 339,143
−Removed: May 1, 2023 - May 31, 2023 84 $ 94.28 — $ 339,143
+Added: June 1, 2023 - June 30, 2023 81 $ 132.94 — $ 339,143
+Added: July 1, 2023 - July 31, 2023 291,883 $ 82.71 284,253 $ 315,143
+Added: August 1, 2023 - August 31, 2023 36,640 $ 84.21 35,852 $ 312,144
Total 328,604 $ 84.29 320,105
1 unchanged sentence
(2) Includes shares repurchased as part of the Company’s share repurchase program initiated in September of 2021.
−Removed: Exhibit Description
−Removed: 2.1 Agreement and Plan of Merger dated as of November 19, 2021 by and among Concentrix Corporation, CNXC Merger Sub, Inc., ProKarma Holdings Inc.
−Removed: and Carlyle Partners VI Holdings, L.P.
−Removed: (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on November 24, 2021).
−Removed: 2.2 First Amendment to Agreement and Plan of Merger, dated as of December 20, 2021, by and among Concentrix Corporation, CNXC Merger Sub, Inc., ProKarma Holdings Inc.
−Removed: and Carlyle Partners VI Holdings, L.P.
−Removed: (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 23, 2021).
−Removed: 2.3 Share Purchase and Contribution Agreement, dated June 12, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 12, 2023).
−Removed: 3.1 Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on December 2, 2020).
−Removed: 3.2 Amended and Restated Bylaws of the Company, as amended (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K filed on January 28, 2022).
−Removed: 10.1 Put Option Agreement, dated as of March 29, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative, including the form of Sellers’ Note set forth as Schedule 7 thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
−Removed: 10.2 Investor Rights Agreement, dated as of March 29, 2023, by and among Concentrix Corporation and the initial stockholders party thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
−Removed: 10.3 Commitment Letter, dated as of March 29, 2023, by and between Concentrix Corporation and JPMorgan Chase Bank, N.A (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
−Removed: 10.4 Amendment and Restatement Agreement, dated as of April 21, 2023, by and among Concentrix Corporation, the lenders party thereto, JPMorgan Chase Bank, N.A., and Bank of America, N.A.
−Removed: (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 26, 2023).
−Removed: 99.1 Voting and Support Agreement, dated March 29, 2023, by and among Concentrix Corporation, Marnix Lux SA, and certain stockholders of Concentrix Corporation (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
−Removed: 31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
−Removed: 31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
−Removed: 32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C.
−Removed: 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
−Removed: 101.SCH Inline XBRL Taxonomy Extension Schema Document
−Removed: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
−Removed: * Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K.
−Removed: Concentrix Corporation hereby undertakes to furnish copies of any of the omitted schedules and exhibits upon request by the U.S.
−Removed: Securities and Exchange Commission.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: July 7, 2023 CONCENTRIX CORPORATION
−Removed: /s/ Christopher Caldwell
−Removed: Christopher Caldwell
−Removed: President and Chief Executive Officer
−Removed: /s/ Andre Valentine
−Removed: Andre Valentine
−Removed: Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.